TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Ocumension Therapeutics ( (HK:1477) ) just unveiled an update.
Ocumension Therapeutics has announced the composition of its board of directors and the roles of each member, highlighting the leadership structure and committee memberships. This announcement provides clarity on the governance of the company, which is crucial for stakeholders to understand the decision-making framework and oversight within the organization.
The most recent analyst rating on (HK:1477) stock is a Buy with a HK$7.29 price target. To see the full list of analyst forecasts on Ocumension Therapeutics stock, see the HK:1477 Stock Forecast page.
More about Ocumension Therapeutics
Ocumension Therapeutics is a company incorporated in the Cayman Islands, operating in the pharmaceutical industry with a focus on developing and commercializing ophthalmic products.
Average Trading Volume: 7,170,339
Technical Sentiment Signal: Buy
Current Market Cap: HK$8.57B
For a thorough assessment of 1477 stock, go to TipRanks’ Stock Analysis page.